Triveni Bio
Triveni Bio utilizes a genetics-informed precision medicine platform to develop functional antibodies targeting immunological and inflammatory disorders. The company focuses on identifying and validating therapeutic targets with strong genetic rationale, aiming to improve treatment options for diseases with limited existing therapies.
- Biotechnology
Funding
Raised to date
$231.6MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many immunological and inflammatory (I&I) disorders have limited treatment options due to a lack of validated therapeutic targets and an incomplete understanding of the underlying genetic factors driving disease. Traditional drug development approaches often overlook the genetic heterogeneity within patient populations, leading to suboptimal treatment responses.
Solution
Triveni Bio is developing functional antibodies for immunological and inflammatory disorders using a genetics-informed precision medicine platform. The company identifies and validates novel therapeutic targets with strong genetic rationale, enabling the development of targeted therapies for patient subpopulations with specific genetic profiles. By integrating genetic insights into drug discovery, Triveni Bio aims to improve treatment efficacy and address the unmet needs of patients with I&I disorders. The platform predicts and stratifies patient subpopulations and provides insights into disease mechanisms.
Target Audience
The primary target audience includes patients suffering from immunological and inflammatory disorders, as well as pharmaceutical companies seeking to develop more effective and targeted therapies.
Features
- Proprietary platform for identifying and validating therapeutic targets with strong genetic rationale
- Development of functional antibodies targeting immunological and inflammatory disorders
- Patient stratification based on genetic profiles to predict treatment response
- Insights into disease mechanisms through genetic analysis